PT  - JOURNAL ARTICLE
AU  - Antoine Salzmann
AU  - Nish Chaturvedi
AU  - Victoria Garfield
TI  - The relationship between cognitive function, Alzheimer’s disease and sleep duration: A Mendelian randomisation study
AID  - 10.1101/2020.09.08.20190611
DP  - 2020 Jan 01
TA  - medRxiv
PG  - 2020.09.08.20190611
4099  - http://medrxiv.org/content/early/2020/09/10/2020.09.08.20190611.short
4100  - http://medrxiv.org/content/early/2020/09/10/2020.09.08.20190611.full
AB  - Objective Sleep duration is associated with cognitive function and dementia. MR evidence to date, points towards a causal relationship in this direction. However, whether cognitive function or dementia may also cause problematic sleep duration remains unclear.Methods We conducted summary-level Mendelian Randomisation (MR) analyses to estimate the causal association between general cognitive function, ‘g’ (177 SNPs), reaction time (44 SNPs), Alzheimer’s disease (AD) (29 SNPs), and self-reported and objective sleep duration. Sensitivity analyses included: MR-Egger, Weighted median estimator and leave-one-out analyses. We used data from recently published cognitive function, AD and sleep duration genome wide association studies.Results MR results showed that AD was associated with longer, (ß = 0.14, 95% CI = 0.04;0.24), whilst ‘g’, and reaction time were associated with shorter (ß = −0.06, 95% CI = −0.11;-0.01 and ß = −0.15, 95% CI = −0.29;-0.01, respectively), objective sleep duration. No association was observed between our exposures and self-reported sleep duration.Interpretation These results suggest a causative relationship between AD, ‘g’, reaction time and objective sleep duration, where AD is associated with longer sleep duration and ‘g’ and reaction time are associated with shorter sleep. This study furthers our understanding of the relationship between brain health and sleep duration and sheds light on the causal nature of these associations.Competing Interest StatementThe authors have declared no competing interest.Funding StatementVG is funded by a joint Diabetes UK/British Heart Foundation grant (15/0005250). AS and NC are supported by the UK Medical Research Council (MC_ST_LHA_2019, MC_UU_0019/2).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Used previously published Genome Wide Association Study results. Relevant IRB approval were obtained for these studies and outlined in their research papers.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe study uses publicly available data from published Genome Wide Associations Studies.